Serum Albumin Injection is a life-saving intravenous therapy used to restore blood volume, maintain plasma oncotic pressure, and manage low albumin levels in critically ill patients. It plays an important role in intensive care units (ICUs), emergency medicine, liver disease management, burn care, and post-surgical recovery.
Medizalbu, the premium Serum Albumin Injection from Medizia Biotech, is manufactured to meet stringent quality standards, ensuring safety, purity, and efficacy for hospitals, healthcare providers, and distributors. Designed for critical care applications, Medizalbu supports rapid plasma volume expansion and effective management of hypoalbuminemia.
Serum Albumin Injection is a sterile intravenous solution containing purified human albumin, the most abundant protein found in human plasma. Albumin is essential for maintaining blood volume, transporting hormones, drugs, and nutrients, and preserving osmotic pressure within blood vessels.
Medizalbu provides a dependable source of human albumin when the body's natural albumin levels become critically low due to illness or injury.
Medizalbu works by:
Restoring plasma volume during blood loss and shock
Increasing oncotic pressure to reduce edema
Improving circulation in critically ill patients
Supporting fluid balance in the bloodstream
Helping transport essential substances throughout the body
Its rapid action makes it an important component of emergency and intensive care treatment protocols.
Medizalbu is commonly prescribed for:
Hypoalbuminemia
Liver cirrhosis with ascites
Major burns
Severe trauma
Septic shock
Hemorrhagic shock
Surgical blood loss
Plasma exchange procedures
Nephrotic syndrome
Critical care patients
ICU fluid management
Post-operative recovery
Always administer the injection under the supervision of qualified healthcare professionals.
Medizalbu offers several clinical advantages:
Rapid plasma volume expansion
Effective correction of low albumin levels
Improved hemodynamic stability
Reduced tissue edema
High purity and safety standards
Reliable quality for hospital use
Suitable for emergency and critical care settings
Trusted by healthcare professionals
The dosage of Medizalbu depends on:
Patient body weight
Clinical condition
Plasma albumin levels
Blood volume status
Physician assessment
The injection should only be administered intravenously by trained medical professionals in a hospital or clinical setting.
Like all plasma-derived products, Serum Albumin Injection may occasionally cause:
Mild fever
Chills
Headache
Nausea
Allergic reactions
Skin rash
Flushing
Shortness of breath (rare)
Fluid overload in susceptible patients
Patients should be monitored throughout administration for any adverse reactions.
For optimal product stability:
Store according to the labeled storage conditions.
Do not freeze.
Protect from excessive heat and direct sunlight.
Use only if the solution is clear and the container is undamaged.
Always follow the storage instructions provided with the product.
Medizia Biotech is committed to delivering high-quality critical care products for hospitals and healthcare institutions. Medizalbu is developed with a focus on quality, safety, and consistent performance.
Key advantages include:
Premium quality manufacturing
Strict quality control processes
Reliable product availability
Bulk supply capability
Third-party manufacturing services
Contract manufacturing solutions
Distribution support across domestic and international markets
Professional customer support
Medizia Biotech offers:
Bulk orders for hospitals
Government supply support
Institutional procurement
Pharma distributors
Export opportunities
Third-party manufacturing
Private labeling
Contract manufacturing
Franchise support
Whether you are a hospital, pharmaceutical company, distributor, or exporter, Medizia Biotech can provide reliable supply solutions tailored to your business requirements.
It is used to restore plasma volume and treat conditions associated with low albumin levels, including hypoalbuminemia, burns, liver disease, shock, and major surgery.
When administered by qualified healthcare professionals according to approved medical guidelines, Medizalbu is intended to be a safe and effective treatment.
Yes. It is widely used in intensive care units for fluid management and plasma volume expansion when clinically indicated.
Yes. Serum Albumin Injection should only be used under medical supervision and with a valid prescription where applicable.
Medizalbu Serum Albumin Injection from Medizia Biotech is a trusted solution for the management of hypoalbuminemia, plasma volume expansion, and critical care support. With high manufacturing standards, dependable supply capabilities, and comprehensive third-party manufacturing services, Medizia Biotech continues to serve hospitals, distributors, and healthcare providers with quality-driven pharmaceutical products.
For bulk orders, distribution partnerships, contract manufacturing, or export inquiries, contact Medizia Biotech to learn more about Medizalbu and its critical care portfolio.